PRMT1 and glioblastoma: We also demonstrated that the increased inhibitory effect on U87MG GSC growth by combined treatment of both compounds was associated with a stronger downregulation of STAT3-mediated downstream GBM stemness regulators by simultaneously blocking PRMT1 and CaMKIIγ activities (Figure 9).